ADIPOQ and coronary artery disorder: Notably, increased adiponectin levels were significantly associated with elevated risk of all-cause and cardiovascular mortality in subjects with cardiovascular diseases (CVD) (Wu et al., 2014), and as an independent predictor of cardiovascular and all-cause mortality in coronary artery disease patients (Yang et al., 2019).